POA
MNTA

Pergamon Offshore Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Pergamon Offshore Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,765
Closed -$193K – 133
2015
Q3 		$193K Buy
+11,765
New +$241K 0.21% 153

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Pergamon Offshore Advisors's MNTA Position: Q4 2015 in Review

Pergamon Offshore Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2015, closing a stake of 11,765 shares — an estimated $193K sold.

Pergamon Offshore Advisors first reported a position in MNTA in Q3 2015 and held it in 1 quarter. The position peaked at $193K in Q3 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q4 2015.

  • Pergamon Offshore Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Pergamon Offshore Advisors sold 11,765 Momenta Pharmaceuticals, Inc. shares in Q4 2015, an estimated $193K.
  • Pergamon Offshore Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Pergamon Offshore Advisors's Momenta Pharmaceuticals, Inc. position peaked at $193K in Q3 2015.
  • 164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2015.

Based on Pergamon Offshore Advisors's 13F filing for Q4 2015.